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Mechano growth factor (MGF) is an alternatively spliced variant of insulin-like 
growth factor-I (IGF-I). Previous reports have revealed that the MGF in skeletal 
muscles is induced by mechanical overload or muscle injury. In the present study, we 
examined the effect of growth hormone (GH) on MGF expression in C2C12 mouse 
muscle cell lines since GH is the principal regulator of IGF-I. The MGF mRNA 
increased 1 h following GH stimulation whereas IGF-IEa mRNA, which encodes a 
systemic type of IGF-I, increased 4 h following GH stimulation. The diverse expression 
of MGF and IGF-IEa was also observed in the case of muscle injury by using 
bupivacaine in the same cell line. Furthermore, GH induced the increase of MyoD as 
well as M-cadherin expression, the peak of which was parallel to that of MGF. These 
results indicate that GH directly and preferentially increased MGF prior to the 
IGF-IEa expression in C2C12 cells, which may lead to the activation of muscle satellite 
cells. 
 
Insulin-like growth factor-I (IGF-I) plays a role in the skeletal muscle in the development, 
growth, repair, and maintenance of the tissues in an autocrine/paracrine as well as endocrine 
fashion (7, 28). Alternative splicing of the IGF-I gene is known to generate several different 
variants (28). Yang et al. (31) cloned the cDNAs of IGF-I splice variants that are expressed 
in the muscle. These include IGF-IEa and the mechano growth factor (MGF). The former is 
the same as the circulating IGF-I produced by the liver, and the latter is reported to be 
markedly upregulated after mechanical stimulation or damage of muscle tissue (18, 31). 
MGF mRNA is derived by alternative precursor mRNA splicing from the IGF-I gene, which 
has a 52-base-pair insert in rodents or a 49-base-pair insert in humans within the E domain. 
This insertion causes a translational frameshift that results in a different carboxy terminal 
sequence from that of IGF-IEa. Previous reports suggest that MGF possesses a different 
function as compared to IGF-IEa in the muscle cells (27, 29, 31). The IGF-IEa peptide 
transfected into C2C12 myoblast cells caused an increase in cell density and myoblasts fused 
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to form myotubes. On the other hand, transfection of the MGF peptide into C2C12 myoblasts 
led to an increase in the number of mononucleated myoblasts but prevented their 
differentiation (32). Although IGF-I is reported to be involved in the maintenance of muscle 
tissue and plays a critical role in activation of muscle satellite (stem) cells that are required 
for local muscle repair (1, 22), the type of IGF-I isoform that may be involved in the process 
of muscle regeneration remains unknown. 
Growth hormone (GH) is the principal regulator of IGF-I expression in tissues (5, 7). In 
vivo, hypophysectomized rats demonstrated a reduced IGF-I expression in muscle that was 
recovered by GH administration (15, 30). There are also in vitro evidences for IGF-I 
regulation by GH in a mouse C2C12 cell line (9, 24). However, there are no reports to date 
regarding the regulation of MGF by GH in vitro. We previously reported that IGF-IEa and 
MGF in skeletal muscle were differentially regulated by GH administration in GH-deficient 
mice (13). Therefore, we speculate that if GH directly regulates the expression of both 
IGF-IEa and MGF in the muscle cells, GH administration might be able to repair and 
regenerate muscle cells more efficiently via the production of both IGF-IEa and MGF than 
the administration of IGF-I alone. 
The aim of this study was to evaluate the direct effect of GH treatment on the expression 
of IGF-I isoforms in the muscle cells and to clarify whether GH treatment could activate 
satellite cells via MGF production. 
 
MATERIALS AND METHODS 
1. Cell culture 
Mouse C2C12 myoblast cells can differentiate into myotubes under certain experimental 
conditions. The C2C12 cells were incubated at 37°C with 5% CO2 in growth medium 
containing Dulbecco’s modified Eagle medium (DMEM) with 10% horse serum (HS). To 
enable differentiation into myotubes, the medium was exchanged with DMEM containing 
2% HS for 5 days. The cells were then differentiated to myotubes exhibiting morphological 
changes (Fig. 1a). 
2. Stimulation 
We added 100 ng/ml of recombinant human GH (kindly provided by Eli Lilly and 
Company, Tokyo, Japan) or phosphate-buffered saline (PBS) as the control into the cultured 
medium, and cells were harvested after 1, 2, 4, 6, and 8 h for RNA preparation. In the other 
experiment, we used bupivacaine to induce the expression of the IGF-I isoforms resulting 
from myotoxicity in C2C12 cells as described previously (12, 20). We added 0.3 mM of 
bupivacaine or PBS as a control in the culture medium and harvested the cells after 1, 2, 4, 
and 7 days. 
3. Total RNA preparations 
The RNA extraction was performed using TRIzol reagent (Invitrogen, Carlsbad, CA, 
USA) according to the manufacturer’s instructions. The quantity of extracted total RNA was 
determined using the NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, 
DE, USA). 
4. Real-time reverse transcriptase polymerase chain reaction (RT-PCR) 
Structures of mouse IGF-IEa and MGF cDNAs and the position of primers are illustrated 
in Fig. 1b: namely, the reverse primer specific for IGF-IEa was produced complementary to 
the sequences including the boundaries of exon 4 and 6 of the mouse IGF-I cDNA. On the 
other hand, the forward primer specific for MGF was produced complementary to the 
sequences including the boundaries of exon 4 and 5 of the mouse IGF-I cDNA. Primer 
sequences for IGF-IEa and MGF are listed in Table. 1. Primers for 18S rRNA, MyoD, and 
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M-cadherin were designed as described previously (4, 11). We reverse transcribed 500 ng of 
total RNA from C2C12 cells in a total volume of 10 µl using the iScript cDNA Synthesis Kit 
(Bio Rad Laboratories, Hercules, CA, USA) according to the manufacturer’s instruction. 
Real-time PCR detection system (model 7500, Applied Biosystems, Foster, CA, USA) with 
SYBR Premix Ex Taq (Takara, Tokyo, Japan) was used for sample cDNA quantification. 
The nucleotides of PCR products were confirmed by sequencing using a DNA sequencer 
(model 310, Applied Biosystems, Foster, CA, USA). 
5. Data analysis 
Results of the expression of the IGF-I isoforms, MyoD, and M-cadherin were adjusted to 
those of the amplified 18S rRNA and expressed as mean ± SEM. Differences were 
determined by the unpaired t test or ANOVA, as appropriate. A value of p < 0.05 was 
considered significant. 
 
Table 1. Primer pairs of IGF-IEa and MGF used for real-time quantitative PCR. 
IGF-I Ea forward 5′-TGACATGCCCAAGACTCA-3′ 
IGF-I Ea reverse 5′-TGTGGCATTTTCTGCTCCGTGG-3′ 
MGF forward 5′-AGCTGCAAAGGAGAAGGAAAGGAAG-3′ 
MGF reverse 5′-GGTGATGTGGCATTTCCTGCT-3′ 
 
 
Figure 1. (a) Morphological changes in the C2C12 cells before and after differentiation from 
mononucleated myoblasts (upper panel) into mature myotubes (lower panel, arrowhead). (b) 
Schema of the mouse IGF-IEa and MGF cDNAs. The arrows indicate the position of specific 
primers for PCR amplification. (c) Detection of a specific band of IGF-IEa (lane 1) or MGF (lane 
2) cDNA in the C2C12 cells. Products amplified by RT-PCR were separated on 2% agarose gel 
and visualized with ethidium bromide staining. M denotes the molecular weight marker. 
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RESULTS 
1. Expression of IGF-IEa and MGF in C2C12 cells 
In a preliminary study, we used RT-PCR to examine whether the IGF-IEa and MGF 
mRNAs are expressed in C2C12 cells. Using the primer pairs as described, specific bands 
were detected (Fig. 1c) and their nucleic sequences were confirmed as mouse IGF-IEa and 
MGF (IGF-IEb), respectively, by sequencing analysis (data not shown). 
2. Effects of GH on IGF-IEa and MGF expression in C2C12 cells 
The mRNA levels of both IGF-IEa and MGF were upregulated by 100 ng/ml GH. As 
illustrated in Fig. 2, the MGF mRNA increased 1 h after stimulation by GH. In contrast, 
IGF-IEa mRNA slowly increased at 4 h and reached the peak level at 6 h after stimulation. 
3. Effects of chemical damage by bupivacaine on the expression of IGF-IEa and MGF 
in C2C12 cells 
To evaluate whether or not the diverse expression of MGF from IGF-IEa in vitro is 
specific for the stimulation by GH, we next investigated the expression of IGF-I isoforms 
after the stimulation by bupivacaine, which caused cell damage in muscle tissue and induced 
MGF expression (11, 12, 20). As illustrated in Fig. 3, the MGF mRNA increased at 1 day 
whereas IGF-IEa significantly increased 7 days after the addition of bupivacaine. 
4. Expression of markers of activated satellite cells after the stimulation by GH in 
C2C12 cells 
Proliferating myoblasts derived from satellite cells express MyoD, a member of muscle 
regulatory transcription factors (25), or adhesion molecules such as M-cadherin (14). 
Therefore, we examined the MyoD and M-cadherin gene expressions after the stimulation by 
GH in C2C12 cells as a marker of activated satellite cells. As illustrated in Fig. 4, bimodal 
increase of MyoD was observed 1 h and 6 h after stimulation by GH. The significant increase 
in M-cadherin was observed at 1 h but not at 6 h after the stimulation. 
 
Figure 2. GH increased the expression of MGF and IGF-IEa in C2C12 cells. The mRNA levels of 
MGF (upper panel) and IGF-IEa (lower panel) was increased and the peak levels were reached at 1 h 
and 6 h, respectively, following stimulation by 100 ng/ml of GH. *p < 0.05, **p < 0.01 vs. time point 0 
(n = 5 in each group). 
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Figure 3. Chemical damage on the C2C12 cells induced the expressions of MGF (upper panel) and 
IGF-IEa (lower panel) on days 1 and 7, respectively, after treatment with bupivacaine. *p < 0.05, **p < 
0.01 vs. time point 0 (n = 5 in each group). 
 
 
Figure 4. GH induced the bimodal expression of MyoD (upper panel) 1 h and 6 h after the 
stimulation by GH. On the other hand, GH increased M-cadherin expression 1 h but not 6 h after 
the stimulation by GH (lower panel). *p < 0.05, **p < 0.01 vs. time point 0 (n = 5 in each group). 
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DISCUSSION 
The main finding of the present study is that in C2C12 cells, the expression of both MGF 
and IGF-IEa was directly but differentially regulated by GH. Furthermore, GH probably 
activated the muscle satellite cells via the production of MGF and IGF-IEa. We believe that 
this is the first report in terms of the direct effect of GH on the expression of IGF-I isoforms 
and on the elevation of markers for the activation of satellite cells. Since GH preferentially 
increased MGF prior to IGF-IEa production, our results suggest that GH may have a 
potential to regenerate muscle cells more effectively than IGF-I alone. 
Several lines of evidence indicate that MGF is regulated by mechanical overload or 
chemical damage to the muscle tissue. In vivo, MGF and IGF-IEa were maximally expressed 
as early as 1 day and 7 days following stretch stimulation in the rat anterior tibialis muscle, 
respectively (12). On the other hand, MGF and IGF-IEa were maximally expressed 4 days 
and 11 days following the chemical damage by the bupivacaine injection, respectively, in the 
same animal models (12). In the C2C12 cells in vitro, MGF was upregulated by a single 
ramp stretch and by cycling loading whereas IGF-IEa was increased by a single ramp stretch 
but reduced by repeated cyclic stretch (3). Thus, previous reports regarding the regulation of 
MGF mRNA expression in skeletal muscles have emphasized the role of mechanical signals 
or muscle injury. On the other hand, we previously reported that GH preferentially induced 
expression of MGF prior to that of IGF-IEa in vivo in GH-deficient mice (13). However, 
since the acute injection of GH in vivo had an effect on several parameters such as serum 
glucose or insulin levels and freely moving animal models were used, it remains unclear 
whether the increased MGF in GH-deficient mice was achieved due to the direct effect of 
GH or via other factors including exercise per se. In this study, to investigate whether or not 
GH directly regulates MGF expression and production, we used an in vitro approach using 
C2C12 cells subjected to addition of GH in the culture medium. As a result, we demonstrated 
that GH directly regulated both MGF and IGF-IEa mRNA expressions. More importantly, 
MGF expression increased more rapidly than that of IGF-IEa by GH stimulation; that was 
consistent with the in vivo result we previously described in GH-deficient mice (13). This 
result suggests that GH not only upregulated the primary transcript of the IGF-I gene but also 
affected the splicing toward the preferential induction of MGF. We next investigated the 
effect of myotoxicity by bupivacaine in the same cell line to address whether or not the 
preferential expression of MGF in C2C12 cells was specifically due to the stimulation of GH. 
In this experiment, MGF mRNA was preferentially expressed followed by the increased 
expression of IGF-IEa although both the expressions stimulated by bupivacaine were slower 
than those stimulated by GH. Our results are consistent with the in vivo result described by 
Hill et al. (12). Taken together, it appears that the expression pattern for each IGF-I splice 
variant is considerably similar in both myotoxin-induced chemical damage and 
GH-stimulated cell models, with MGF peaking before IGF-IEa. 
Another relevant finding in the present study is that GH induced the bimodal increase of 
the MyoD and an early induction of M-cadherin expression. We selected MyoD and 
M-cadherin in the present study as markers for proliferating myoblasts since previous work 
demonstrated that proliferating myoblasts derived from satellite cells express myoblast 
markers such as MyoD and adhesion molecules such as M-cadherin, but not terminal 
differentiation markers such as myogenin or myosin heavy chains (17, 21). Our results 
demonstrate the early induction of M-cadherin as well as MyoD in parallel with MGF 
expression after the addition of GH, consistent with a notion that GH plays a role in the 
activation of the satellite cells via MGF production. The further induction of MyoD was 
probably caused via IGF-IEa production. It remains unclear why no further induction of 
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M-cadherin by GH was observed; however, this suggests that IGF-IEa possesses a relatively 
weak potential in terms of satellite cell proliferation as compared with MGF (31). Liu et al. 
(16) reported that the expression of myostatin, negative regulator of muscle regeneration, in 
C2C12 cells was reduced by GH administration and increased by the administration of a GH 
receptor antagonist. This finding supports the role of GH on muscle cell regeneration. There 
are several lines of evidence indicating that IGF-I can potentially maintain the skeletal 
muscle volume and prevent cell death in skeletal muscles (1, 22). Coleman et al. (6) reported 
that myogenic vector expression of IGF-I stimulated muscle cell differentiation and myofiber 
hypertrophy. Musaro et al. (19) demonstrated that localized IGF-I transgene expression in 
muscle induced local muscle hypertrophy and prevented the age-related decline in muscle 
mass. However, these experiments did not distinguish the role of each IGF-I isoform. On the 
other hand, transgenic mice with skeletal muscle-specific overexpression of IGF-IEa did not 
increase myoblast proliferation (26). Mice with muscle-specific inactivation of the IGF-I 
receptor exhibited marked muscle hypoplasia from birth to 3 weeks of age, but the mice 
exhibited hyperplasia in skeletal muscle from 3 weeks to adulthood (8). These results suggest 
that other factors independent of IGF-I receptor signaling such as MGF may play a relevant 
role in the early events of tissue repair in skeletal muscle. Repair and regeneration of muscle 
tissue require 2 distinct processes; one is the replication of the mononucleated myoblasts and 
the other is the fusion of myoblasts with muscle fibers. MGF has a potential of inducing 
myoblast proliferation but prevents their differentiation (32), which would be favorable as it 
facilitates conservation of the satellite cell pools. Thus, IGF-IEa in combination with MGF 
could repair the muscle tissue more efficiently than IGF-IEa alone. Aging in humans is 
characterized by a loss of muscle strength and mass, and also by a gradual decline in 
circulating GH (23). As discussed by Hameed et al. (10), GH may be crucial to facilitate the 
increase of MGF in combination with exercise. It is possible that sarcopenia in elderly may 
be linked to MGF impairment as well as reduced serum GH levels (2). 
In conclusion, we demonstrated that GH directly and preferentially induces MGF 
followed by IGF-IEa expression, which may lead to the activation of muscle satellite cells.  
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